Barriers to early detection of cognitive impairment in the elderly despite the availability of simple cognitive screening tools and the pharmacist’s role in early detection and referral

2.50
Hdl Handle:
http://hdl.handle.net/2436/620578
Title:
Barriers to early detection of cognitive impairment in the elderly despite the availability of simple cognitive screening tools and the pharmacist’s role in early detection and referral
Authors:
Abed, H; Ball, Patrick ( 0000-0001-8918-2119 ) ; Morrissey, Hana
Abstract:
Aim The aim of this review is to identify a suitable cognitive screening tool that can be used by the pharmacist during home medication review in addition to calculating the medications’ total anticholinergic burden (ACB). Data sources A search of the literature was conducted using PubMed, Embase, Medline and Google Scholar databases to identify relevant studies using the following keywords: ‘cognitive impairment’, ‘cognitive impairment AND diagnosis’, ‘cognitive scales’, ‘dementia’, ‘delirium’, ‘pharmacist role’, ‘mini-mental state examination (MMSE)’, ‘the Rowland dementia assessment scale (RUDAS)’, ‘the Alzheimer's Disease Assessment Scale - Cognition (ADAS-Cog)’ and ‘barriers and problems’. Only informational websites, clinical trials and review articles were included. Results The MMSE, RUDAS, ADAS-Cog, Psychogeriatric Assessment Scale (PAS) and Kimberley Indigenous Cognitive Assessment (KICA-Cog) require specialist training. The anxiety and depression checklist (K10) and ‘worried about your memory’ (WAYM) can be self-administered without prior training. The ACB scoring system can also be used to determine the total medications ACB. Conclusion The K10 and WAYM can be used by the pharmacist during medication reviews to detect cognitive impairment early and refer the elderly for further medical care supported by the calculated score for the patient‘s total medications‘ ACB.
Citation:
Abed, H., Ball, P. and Morrissey, H. (2017), Barriers to early detection of cognitive impairment in the elderly despite the availability of simple cognitive screening tools and the pharmacist's role in early detection and referral. J Pharm Pract Res. doi:10.1002/jppr.1252
Publisher:
Society of Hospital Pharmacists of Australia available via Wiley Online Library
Journal:
Journal of Pharmacy Practice and Research
Issue Date:
Jul-2017
URI:
http://hdl.handle.net/2436/620578
Additional Links:
http://onlinelibrary.wiley.com/doi/10.1002/jppr.1252/abstract;jsessionid=12F81B77CCBE93C496170D67581145E6.f02t01?systemMessage=Wiley+Online+Library+will+be+unavailable+on+Saturday+12th+August+at+3%3A00+EDT+%2F+8%3A00+BST+%2F+12%3A30+IST+%2F+15%3A00+SGT+for+4+hours+for+essential+maintenance.+Apologies+for+the+inconvenience.
Type:
Article
Language:
en
ISSN:
1445-937X
Appears in Collections:
FSE

Full metadata record

DC FieldValue Language
dc.contributor.authorAbed, Hen
dc.contributor.authorBall, Patricken
dc.contributor.authorMorrissey, Hanaen
dc.date.accessioned2017-08-10T13:24:56Z-
dc.date.available2017-08-10T13:24:56Z-
dc.date.issued2017-07-
dc.identifier.citationAbed, H., Ball, P. and Morrissey, H. (2017), Barriers to early detection of cognitive impairment in the elderly despite the availability of simple cognitive screening tools and the pharmacist's role in early detection and referral. J Pharm Pract Res. doi:10.1002/jppr.1252en
dc.identifier.issn1445-937Xen
dc.identifier.urihttp://hdl.handle.net/2436/620578-
dc.description.abstractAim The aim of this review is to identify a suitable cognitive screening tool that can be used by the pharmacist during home medication review in addition to calculating the medications’ total anticholinergic burden (ACB). Data sources A search of the literature was conducted using PubMed, Embase, Medline and Google Scholar databases to identify relevant studies using the following keywords: ‘cognitive impairment’, ‘cognitive impairment AND diagnosis’, ‘cognitive scales’, ‘dementia’, ‘delirium’, ‘pharmacist role’, ‘mini-mental state examination (MMSE)’, ‘the Rowland dementia assessment scale (RUDAS)’, ‘the Alzheimer's Disease Assessment Scale - Cognition (ADAS-Cog)’ and ‘barriers and problems’. Only informational websites, clinical trials and review articles were included. Results The MMSE, RUDAS, ADAS-Cog, Psychogeriatric Assessment Scale (PAS) and Kimberley Indigenous Cognitive Assessment (KICA-Cog) require specialist training. The anxiety and depression checklist (K10) and ‘worried about your memory’ (WAYM) can be self-administered without prior training. The ACB scoring system can also be used to determine the total medications ACB. Conclusion The K10 and WAYM can be used by the pharmacist during medication reviews to detect cognitive impairment early and refer the elderly for further medical care supported by the calculated score for the patient‘s total medications‘ ACB.en
dc.language.isoenen
dc.publisherSociety of Hospital Pharmacists of Australia available via Wiley Online Libraryen
dc.relation.urlhttp://onlinelibrary.wiley.com/doi/10.1002/jppr.1252/abstract;jsessionid=12F81B77CCBE93C496170D67581145E6.f02t01?systemMessage=Wiley+Online+Library+will+be+unavailable+on+Saturday+12th+August+at+3%3A00+EDT+%2F+8%3A00+BST+%2F+12%3A30+IST+%2F+15%3A00+SGT+for+4+hours+for+essential+maintenance.+Apologies+for+the+inconvenience.en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectcognitive impairmenten
dc.subjectcognitive screening testsen
dc.subjectpharmacist’s roleen
dc.subjectmedication reviewen
dc.titleBarriers to early detection of cognitive impairment in the elderly despite the availability of simple cognitive screening tools and the pharmacist’s role in early detection and referralen
dc.typeArticleen
dc.identifier.journalJournal of Pharmacy Practice and Researchen
dc.date.accepted2017-01-
rioxxterms.funderInternalen
rioxxterms.identifier.projectUoW100817HMen
rioxxterms.versionAMen
rioxxterms.licenseref.urihttps://creativecommons.org/CC BY-NC-ND 4.0en
rioxxterms.licenseref.startdate2019-02-01en
This item is licensed under a Creative Commons License
Creative Commons
All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.